New Research Collaboration Aims to Advance Personalized Cancer Treatment
GE HealthCare and Mayo Clinic have launched the MI-BET research collaboration to…
Global Oncology Pipeline Set to Expand With Next-Generation Cancer Drug Innovation
Novartis will acquire UK-based Myricx Bio in a deal worth up to…
Boehringer Ingelheim launches three phase III trials in precision Oncology
Boehringer Ingelheim has initiated three Phase III clinical trials aimed at advancing…
Johnson & Johnson expands access to liquid biopsy testing for lung cancer patients in the UAE
Johnson & Johnson expands access to liquid biopsy testing in the UAE,…
Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology
Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company founded by pioneers…
Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study
Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6)…
M42, AstraZeneca, and SOPHiA GENETICS launch UAE broad liquid biopsy initiative to transform cancer diagnosis and care
M42, a global health leader powered by technology, continues to pioneer artificial…
Cleveland Clinic Abu Dhabi, M42, and Gunma University Collaborate to Advance Heavy Ion Cancer Therapy
: M42, a global health champion powered by AI and technology, and…
